GASTRIC AND ESOPHAGEAL CANCER DRUGS MARKET ANALYSIS

Gastric and Esophageal Cancer Drugs Market, by Therapy Type (Chemotherapy, Targeted Therapy, and Immunotherapy), by Disease Condition (Adenocarcinomas, Gastrointestinal Stromal Tumors, Carcinoid Tumors, Squamous Cell Carcinoma, and Others), by Distribution Channel (Hospital, Retail Pharmacy, and Online Pharmacy), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI2438
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Key players for the gastric and esophageal cancer drugs market include Amgen, Eli Lilly and Company, F. Hoffmann-La Roche, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, GlaxoSmithKline Plc., Novartis AG, Johnson & Johnson, Gilead Sciences, Merck & Co., and others.